Togliardi, Elena

National Cancer Institute of Milan, Milan, Italy

1 paper on CoChat

Most cited papers

Verified
An open-label, single-group, phase 2 study of brentuximab vedotin as salvage therapy for males with relapsed germ-cell tumors (GCT): Results at the end of first stage (FM12GCT01).
Necchi, A., Magazzu, D., Anichini, A., Raggi, D., Giannatempo, P., Nicolai, N., Colecchia, M., Paolini, B., Coradeschi, E., Tassi, E., et al. (2016) · Journal of Clinical Oncology
Testicular diseases and treatmentsLymphoma Diagnosis and Treatment
Cited by 17

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free